AWA
PDSB icon

Arkadios Wealth Advisors’s PDS Biotechnology PDSB Stock Holding History

Arkadios Wealth Advisors’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-500
Closed -$7K – 1418
2021
Q3 		$7K Hold
500
– – ﹤0.01% 1530
2021
Q2 		$6K Hold
500
– – ﹤0.01% 1683
2021
Q1 		$2K Buy
+500
New +$2.01K ﹤0.01% 1535

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arkadios Wealth Advisors's PDSB Position: Q4 2021 in Review

Arkadios Wealth Advisors sold out of PDS Biotechnology (PDSB) in Q4 2021, closing a stake of 500 shares — an estimated $7K sold.

Arkadios Wealth Advisors first reported a position in PDSB in Q1 2021 and held it in 3 quarters. The position peaked at $7K in Q3 2021. 65 funds tracked by Wall St. Rank hold PDSB as of Q4 2021.

  • Arkadios Wealth Advisors reported no remaining PDS Biotechnology position as of Q4 2021 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 500 PDS Biotechnology shares in Q4 2021, an estimated $7K.
  • Arkadios Wealth Advisors first reported a position in PDS Biotechnology in Q1 2021 and held it in 3 quarters.
  • Arkadios Wealth Advisors's PDS Biotechnology position peaked at $7K in Q3 2021.
  • 65 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.